CoChat

Accelerated differentiation of human induced pluripotent stem cells to blood–brain barrier endothelial cells

Open access

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

Due to their ability to limitlessly proliferate and specialize into almost any cell type, human induced pluripotent stem cells (iPSCs) offer an unprecedented opportunity to generate human brain microvascular endothelial cells (BMECs), which compose the blood–brain barrier (BBB), for research purposes. Unfortunately, the time, expense, and expertise required to differentiate iPSCs to purified BMECs precludes their widespread use. Here, we report the use of a defined medium that accelerates the differentiation of iPSCs to BMECs while achieving comparable performance to BMECs produced by established methods. Induced pluripotent stem cells were seeded at defined densities and differentiated to BMECs using defined medium termed E6. Resultant purified BMEC phenotypes were assessed through trans-endothelial electrical resistance (TEER), fluorescein permeability, and P-glycoprotein and MRP family efflux transporter activity. Expression of endothelial markers and their signature tight junction proteins were confirmed using immunocytochemistry. The influence of co-culture with astrocytes and pericytes on purified BMECs was assessed via TEER measurements. The robustness of the differentiation method was confirmed across independent iPSC lines. The use of E6 medium, coupled with updated culture methods, reduced the differentiation time of iPSCs to BMECs from thirteen to 8 days. E6-derived BMECs expressed GLUT-1, claudin-5, occludin, PECAM-1, and VE-cadherin and consistently achieved TEER values exceeding 2500 Ω × cm 2 across multiple iPSC lines, with a maximum TEER value of 4678 ± 49 Ω × cm 2 and fluorescein permeability below 1.95 × 10 −7 cm/s. E6-derived BMECs maintained TEER above 1000 Ω × cm 2 for a minimum of 8 days and showed no statistical difference in efflux transporter activity compared to BMECs differentiated by conventional means. The method was also found to support long-term stability of BMECs harboring biallelic PARK2 mutations associated with Parkinson’s Disease. Finally, BMECs differentiated using E6 medium responded to inductive cues from astrocytes and pericytes and achieved a maximum TEER value of 6635 ± 315 Ω × cm 2 , which to our knowledge is the highest reported in vitro TEER value to date. Given the accelerated differentiation, equivalent performance, and reduced cost to produce BMECs, our updated methods should make iPSC-derived in vitro BBB models more accessible for a wide variety of applications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12987-017-0059-0

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Differentiation of iPSCs to BMECs. iPSCs were seeded at defined densities and differentiated for either 6 days in unconditioned medium (UM) or for 4 days in defined E6 medium. Impure immature BMECs were subsequently treated for 2 days with endothelial cell (EC) medium supplemented with bFGF and retinoic acid (RA). Mature BMECs were purified onto Transwell filters or plates for 24 h in EC medium supplemented with bFGF and RA. 24 h after purification, barrier was induced by treating cells with EC medium lacking bFGF and RA
Fig. 1 Differentiation of iPSCs to BMECs. iPSCs were seeded at defined densities and differentiated for either 6 days in unconditioned medium (UM) or for 4 days in defined E6 medium. Impure immature BMECs were subsequently treated for 2 days with endothelial cell (EC) medium supplemented with bFGF and retinoic acid (RA). Mature BMECs were purified onto Transwell filters or plates for 24 h in EC medium supplemented with bFGF and RA. 24 h after purification, barrier was induced by treating cells with EC medium lacking bFGF and RACC BY · PubMed Central
Fig. 2 Immunocytochemical analysis of BBB markers before and after purification. a Immunocytochemical detection of PECAM-1 after 4 D E6 medium. Scale bar is 200 μm. b Immunocytochemical detection of GLUT-1, occludin, PECAM-1, and VE-cadherin after 4 D E6 medium and 2 D EC medium supplemented with bFGF and RA. All scale bars are 50 μm. c Immunocytochemical detection of claudin-5, GLUT-1, occludin, PECAM-1, and VE-cadherin following purification and induction of barrier phenotype. All scale bars are 50 μm
Fig. 2 Immunocytochemical analysis of BBB markers before and after purification. a Immunocytochemical detection of PECAM-1 after 4 D E6 medium. Scale bar is 200 μm. b Immunocytochemical detection of GLUT-1, occludin, PECAM-1, and VE-cadherin after 4 D E6 medium and 2 D EC medium supplemented with bFGF and RA. All scale bars are 50 μm. c Immunocytochemical detection of claudin-5, GLUT-1, occludin, PECAM-1, and VE-cadherin following purification and induction of barrier phenotype. All scale bars are 50 μmCC BY · PubMed Central
Fig. 3 BMECs differentiated using UM and E6 medium demonstrate equivalent maximum TEER and stability. For each medium, three filters were seeded with BMECs, and TEER was measured in three different positions for each filter. Each plot is the result of one biological replicate (n = 1) with each daily TEER measurement the result of a technical n = 9. Values are reported as mean ± standard deviation of these collective measurements. a BMECs differentiated using E6 medium demonstrated maximum TEER values of at least 2500 Ω × cm2 for a minimum of 11 days in three biological replicates (i–iii). TEER was measured approximately every 24 h for the duration of the experiment. b BMECs differentiated using UM demonstrated maximum TEER values of at least 2500 Ω × cm2 for a minimum of 12 days in three biological replicates (i–iii). TEER was measured approximately every 24 h for the duration of the experiment
Fig. 3 BMECs differentiated using UM and E6 medium demonstrate equivalent maximum TEER and stability. For each medium, three filters were seeded with BMECs, and TEER was measured in three different positions for each filter. Each plot is the result of one biological replicate (n = 1) with each daily TEER measurement the result of a technical n = 9. Values are reported as mean ± standard deviation of these collective measurements. a BMECs differentiated using E6 medium demonstrated maximum TEER values of at least 2500 Ω × cm2 for a minimum of 11 days in three biological replicates (i–iii). TEER was measured approximately every 24 h for the duration of the experiment. b BMECs differentiated using UM demonstrated maximum TEER values of at least 2500 Ω × cm2 for a minimum of 12 days in three biological replicates (i–iii). TEER was measured approximately every 24 h for the duration of the experimentCC BY · PubMed Central
Fig. 4 E6-derived BMECs and UM-derived BMECs demonstrate equivalent efflux transporter activity. E6-derived BMECs and UM-derived BMECs were incubated with rhodamine 123 (R123) or H2DCFDA in the presence and absence of efflux transporter inhibitors, PSC833 and MK-571, respectively. Fluorescence accumulation within cells incubated with fluorescent substrate in the presence of the desired inhibitor was normalized to fluorescence accumulation in cells incubated with substrate but with no inhibitor. Each condition was performed using triplicate wells, and cell count per condition was calculated as an average from 6 images taken from 1 additional well for each condition. All fluorescence values are normalized on per-cell basis and reported as normalized mean fluorescence ± standard deviation. Two-way ANOVA analysis indicates no statistical difference (p > 0.05) in fluorescence accumulation between E6-derived BMECs and UM-derived BMECs. All substrate and inhibitor conditions were repeated in an additional independent differentiation per medium to confirm reported trends
Fig. 4 E6-derived BMECs and UM-derived BMECs demonstrate equivalent efflux transporter activity. E6-derived BMECs and UM-derived BMECs were incubated with rhodamine 123 (R123) or H2DCFDA in the presence and absence of efflux transporter inhibitors, PSC833 and MK-571, respectively. Fluorescence accumulation within cells incubated with fluorescent substrate in the presence of the desired inhibitor was normalized to fluorescence accumulation in cells incubated with substrate but with no inhibitor. Each condition was performed using triplicate wells, and cell count per condition was calculated as an average from 6 images taken from 1 additional well for each condition. All fluorescence values are normalized on per-cell basis and reported as normalized mean fluorescence ± standard deviation. Two-way ANOVA analysis indicates no statistical difference (p > 0.05) in fluorescence accumulation between E6-derived BMECs and UM-derived BMECs. All substrate and inhibitor conditions were repeated in an additional independent differentiation per medium to confirm reported trendsCC BY · PubMed Central
Fig. 5 BMEC differentiation using E6 medium translates to additional iPSC lines. iPSC lines CD12, CC3, and SM14 were differentiated to BMECs with E6 medium as described in Fig. 1, and TEER was measured approximately every 24 h. For each differentiation, three filters were seeded with BMECs, and each filter was measured at three locations on the filter. Each plot is the result of one biological replicate (n = 1) with each daily TEER measurement the result of a technical n = 9. All values are mean ± standard deviation of these nine total measurements per condition. a CD12-derived BMECs achieved maximum TEER values exceeding 4000 Ω × cm2 and maintained TEER above 1000 Ω × cm2 for a minimum of 11 days in 3 independent biological replicates. b CC3-derived BMECs achieved maximum TEER values exceeding 3500 Ω × cm2 and maintained TEER above 1000 Ω × cm2 for a minimum of 8 days in 3 independent biological replicates. c SM14-derived BMECs achieved maximum TEER values exceeding 2500 Ω × cm2 and maintained TEER above 1000 Ω × cm2 for a minimum of 11 days in 3 independent biological replicates. d Apical-to-basolateral flux of rhodamine 123 (R123) and H2DCFDA was measured across BMECs in the presence or absence of PSC833 and MK-571, respectively. Fluorescence was normalized to cells not treated with inhibitor and reported as normalized mean fluorescence ± standard deviation. Each condition was performed using triplicate filters and statistics were calculated using a technical n of 3. Statistical significance was determined using the Student’s unpaired t test (*p < 0.1; **p < 0.05; ***p < 0.01). Data from one biological experiment are shown, and an additional biological replicate was performed for each line to verify the observed trends. e The permeability of sodium fluorescein was measured across BMECs. Each experiment was performed using triplicate filters and data are presented as mean ± standard deviation. Biological duplicates were used to verify each measurement. The effective permeability (Pe) was calculated at less than 1.95 × 10−7 cm/s for all lines
Fig. 5 BMEC differentiation using E6 medium translates to additional iPSC lines. iPSC lines CD12, CC3, and SM14 were differentiated to BMECs with E6 medium as described in Fig. 1, and TEER was measured approximately every 24 h. For each differentiation, three filters were seeded with BMECs, and each filter was measured at three locations on the filter. Each plot is the result of one biological replicate (n = 1) with each daily TEER measurement the result of a technical n = 9. All values are mean ± standard deviation of these nine total measurements per condition. a CD12-derived BMECs achieved maximum TEER values exceeding 4000 Ω × cm2 and maintained TEER above 1000 Ω × cm2 for a minimum of 11 days in 3 independent biological replicates. b CC3-derived BMECs achieved maximum TEER values exceeding 3500 Ω × cm2 and maintained TEER above 1000 Ω × cm2 for a minimum of 8 days in 3 independent biological replicates. c SM14-derived BMECs achieved maximum TEER values exceeding 2500 Ω × cm2 and maintained TEER above 1000 Ω × cm2 for a minimum of 11 days in 3 independent biological replicates. d Apical-to-basolateral flux of rhodamine 123 (R123) and H2DCFDA was measured across BMECs in the presence or absence of PSC833 and MK-571, respectively. Fluorescence was normalized to cells not treated with inhibitor and reported as normalized mean fluorescence ± standard deviation. Each condition was performed using triplicate filters and statistics were calculated using a technical n of 3. Statistical significance was determined using the Student’s unpaired t test (*p < 0.1; **p < 0.05; ***p < 0.01). Data from one biological experiment are shown, and an additional biological replicate was performed for each line to verify the observed trends. e The permeability of sodium fluorescein was measured across BMECs. Each experiment was performed using triplicate filters and data are presented as mean ± standard deviation. Biological duplicates were used to verify each measurement. The effective permeability (Pe) was calculated at less than 1.95 × 10−7 cm/s for all linesCC BY · PubMed Central
Fig. 6 E6-derived BMECs respond to inductive cues from astrocytes and pericytes. a Co-culture of CD12-derived BMECs with astrocytes, pericytes, and a mixture of astrocytes and pericytes achieved maximum TEER values exceeding 4000 Ω × cm2 and maintained TEER above 1000 Ω × cm2 for a minimum of 22 days under all co-culture conditions. Each condition was conducted on triplicate filters with all BMECs purified from a single differentiation. Each filter was measured at three different locations on the filter each day. Values are mean ± standard deviation from these collective nine technical replicates per condition per day. Maximum TEER values achieved on day 8 of subculture were normalized to the TEER of the monoculture control. Statistical significance was calculated using Student’s unpaired t test. b CC3-derived BMECs were co-cultured with a mixture of astrocytes and pericytes, achieving a significant increase in TEER 24 h after barrier induction (p < 10−5, Student’s unpaired t test). Each condition was conducted on triplicate filters with all BMECs purified from a single differentiation. Each filter was measured at three different locations on the filter each day. Values are mean ± standard deviation from these collective nine technical replicates per condition per day. BMECs were subsequently stained for occludin and claudin-5 in both control and co-culture conditions. Scale bars are 50 μm
Fig. 6 E6-derived BMECs respond to inductive cues from astrocytes and pericytes. a Co-culture of CD12-derived BMECs with astrocytes, pericytes, and a mixture of astrocytes and pericytes achieved maximum TEER values exceeding 4000 Ω × cm2 and maintained TEER above 1000 Ω × cm2 for a minimum of 22 days under all co-culture conditions. Each condition was conducted on triplicate filters with all BMECs purified from a single differentiation. Each filter was measured at three different locations on the filter each day. Values are mean ± standard deviation from these collective nine technical replicates per condition per day. Maximum TEER values achieved on day 8 of subculture were normalized to the TEER of the monoculture control. Statistical significance was calculated using Student’s unpaired t test. b CC3-derived BMECs were co-cultured with a mixture of astrocytes and pericytes, achieving a significant increase in TEER 24 h after barrier induction (p < 10−5, Student’s unpaired t test). Each condition was conducted on triplicate filters with all BMECs purified from a single differentiation. Each filter was measured at three different locations on the filter each day. Values are mean ± standard deviation from these collective nine technical replicates per condition per day. BMECs were subsequently stained for occludin and claudin-5 in both control and co-culture conditions. Scale bars are 50 μmCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 45 references

Cited by

See all 199

Metadata

Authors
Hollmann, E. K., Bailey, A. K., Potharazu, A. V., Neely, M. D., Bowman, A. B., & Lippmann, E. S.
Affiliations
  • Vanderbilt University (US)
  • Vanderbilt University Medical Center (US)
Corresponding author
Lippmann, Ethan S.
Venue
Fluids and Barriers of the CNS
Published
2017-04-13
Volume
14
Issue
1
Pages
9-9
ISSN
2045-8118 (ISSN-L)
OpenAlex
W2605691032
Cited by
189
References
45
Citations by year
2026: 16 · 2025: 19 · 2024: 16 · 2023: 19 · 2022: 27 · 2021: 18 · 2020: 30 · 2019: 24 · 2018: 14 · 2017: 6
FWCI
10.08
Type
journal article
Language
en
Open access
Licence
Locations
  • Fluids and Barriers of the CNS (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institutes of Health (ES010563, ES016931)
Topics
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
human induced pluripotent stem cells, blood-brain barrier endothelial cells, iPSC differentiation, defined culture medium, transendothelial electrical resistance, tight junction proteins, efflux pumps, P-glycoprotein, MRP transporters, astrocyte co-culture, Parkinson's disease, PARK2 mutations
MeSH terms
Astrocytes, Blood-Brain Barrier, Cell Differentiation, Cell Line, Culture Media, Humans, Immunohistochemistry, Male, Time Factors, Pericytes, Endothelial Cells, Culture Techniques, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Accelerated differentiation of human induced pluripotent stem cells to blood–brain barrier endothelial cells. https://app.cochat.ai/papers/10.1186/s12987-017-0059-0
The paper
Hollmann, E. K., Bailey, A. K., Potharazu, A. V., Neely, M. D., Bowman, A. B., & Lippmann, E. S. (2017). Accelerated differentiation of human induced pluripotent stem cells to blood–brain barrier endothelial cells. Fluids and Barriers of the CNS. https://doi.org/10.1186/s12987-017-0059-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.